Navigator Medicines, Inc.

New Filing
CIK: 0002035715·Biotechnology·DELAWARE·Filed: Sep 5, 2024
Total Offering

$99,999,993

Amount Sold

$49,999,998

Investors

4

First Sale

Aug 23, 2024

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2024
Non-Accredited Investors
No

Related Persons

NameRole
STEPHEN BASIL THOMAS
Related Person
WILLIAM DALEY BONIFICIO
Related Person
NAVEEN MANU DARYANI
Related Person
ANDREW LEVIN
Related Person
WOUTER JOUSTRA
Related Person

Company

Navigator Medicines, Inc.

2525 SMITH STREET

SCOTCH PLAINS, NJ, 07076

518-313-0994

SEC Filing

0002035715-24-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free